Here the authors identify rare loss of function variants in GPR10 in people with severe obesity and showed that one of these variants causes obesity when modelled in mice, suggesting that future studies could explore GPR10 as a potential target for weight-loss therapy. This evidence concerns the gene PRLHR and obesity due to melanocortin 4 receptor deficiency.